The Medicines Management Policy & Procedure Group (MMPPG) is the recommendation group for all medicines-related documents across the Trust. This includes documents that are not owned by the Medicines Management Team but include medicines content. 

The purpose of the MMPPG is to ensure sufficient stakeholder engagement, reduce the risk of inconsistent guidance across the Trust, standardise processes and documents, remove the risk of duplication, ensure medicines management oversight of all medicines-related documents, and to ensure that the correct ratification process is followed.

The MMPPG meeting is the 2nd Wednesday of each month. The meeting time is usually 1:30-3:30pm.

All new / updated medicines-related documents must be submitted to MMPPG for recommendation. The MMPPG Submission Form must be completed to ensure that the MMPPG are informed of the rationale, consultation / stakeholder engagement and scope of the document.

You can view all medicines management procedures by visiting the Policies and Procedures section of YourSpace and selecting Trust Wide (for aligned procedures) or the relevant former Division from the drop down bar, and search with the relevant key word.

If a procedure cannot be found on the above page, it may be on a divisional SharePoint page as below:

A list of Trust Wide procedure can be found on the Trust Wide Medicines Related Policies and Procedure tab below.

The policies and procedures listed below are available here.

Trust Wide procedures

MMP01 Safe Management of Controlled Drugs

MMP02 Safe Management of Unidentifiable and Suspected Illicit Substances

MMP03 Administration of Discretionary Medicines

MMP04 Overt and Covert Administration of Medicines in Food/Drink (Inpatients)

MMP05 Self Administration of Medicines (SAM) Scheme

MMP06 Transport, Transfer and Collection of Medicines

MMP07 Medicines Reconciliation for Inpatients

MMP08 Administration of Medicines (inc. Self Administration of Medicines)

MMP09 Safe Use of Injectable Medicines

MMP10 Management of Community Prescriptions

MMP11 Discharge Medicines Services (DMS)

MMP12 

MMP13 Reducing Harm from Omitted or Delayed Time Critical Medicines 

MMP14 Zuclopenthixol Acetate Guidelines and Procedure

MMP15 Administration of the Covid-19 and Seasonal Influenza Vaccination to Trust Inpatients

MMP16 Alcohol Detoxification 

MMP17 Medicines Management in Special Schools

MMP18 Safe Prescribing of Established Methadone / Buprenorphine

MMP19 Transcribing of Medicines in Approved Services

MMP20 Management of Buccal Midazolam

MMP21 Patient Group Direction (PGD) Compliance Audit

MMP22 Take-Home Naloxone (Hope Centre)

MMP23 Safe Use of Valproate

MMP24 Safe Use of Clozapine

MMP25 Patient's Own Drugs

MMP26 High Dose Antipsychotic Therapy (HDAT)

MMP27 Management of Medicines Errors

MMP28 Management of Thickening Agents in SALT Teams for Assessment

MMP29 Management of Anticoagulation Therapy

MMP30 Medical Gas Cylinders Procedure (associated with SD63) - expected 2025

MMP31 Transfer of Inpatient Medicines Records

MMP32 Medicines Management at Huyton CoRe and Cluster

MMP33 Ordering, Receipt and Storage of Medicines

MMP34 Handling and Management of Covid-19 and Influenza Vaccines in and within the Trust

MMP35 EPMA Business Continuity

MMP36

MMP37 Management of Anticipatory Medicines for End of Life Care in Community Childrens Nursing Team 

MMP38 Safe Use of Opioids

MMP39 Use of Unlicensed / Off-label Medicines

MMP40 Administration via a Nasogastric Tube

MMP41 Medicines Management in Knowsley Treatment Rooms

MMP42 Prescribing (Inpatients)

MMP43 Safe Use of Potassium Permanganate

MMP44 Medicines Management at Wavertree Bungalow

MMP45 Administration of Medicines by Health Care Support Workers

MMP46 Medicines Management in the IV Therapy Team

MMP47 Administration of Vaccines by trained Health Support Workers and Registered Nurses delivering GP Vaccination

MMP48 Carrying out Safe and Secure Medicines Audit Spot Checks

MMP49 Pharmaceutical Waste

MMP50 Rapid Tranquillisation

MMP51 Treatment of Anaphylaxis

MMP52 

MMP53 Medicines Management in the ICRAS Team

MMP54 Medicines Management in the ADHD Services

MMP55 Medicines Management in Health Based Places of Safety (HBPoS)

MMP56 Guidelines for the Management of Hyperprolactinaemia

Trust Wide Policies

SD12 Safe and Secure Medicines

MCT08 Controlled Drugs

MM05 Non Medical Prescribing

SA50 Patient Group Directions

SD63 Safe Management of Medical Gas Cylinders

The procedures below are service specific and are applicable to the Medicines Management Team only:

The procedures below are applicable to the Medicines Management Department only and can be found on the S: drive > 'Pharmacy' Folder:

The procedures below are applicable to the Medicines Management Clinical Trials Team only:

The procedures below are applicable to the Medicines Information & Formulary Team only: 

EPMA User Guides / Procedures can be found here on the Medicines Management EPMA intranet page.

Vaccinator Training Pathway 2024/25

Valproate Decision Support Tool - Bipolar: Is valproate the right choice? 

  • Risk assessment for insulin administration by HCSWs
    • To be completed by the register nurse/registered practitioner who will take responsibility for delegation of the task
  • Agreement form to consent to administration of insulin
    • The registered nurse/registered practitioner must obtain informed consent (see Appendix 3) to the delegation of the task from the person receiving care, or where that person does not have the capacity to give consent, the principles of the Mental Capacity Act (2005) should be followed as set out in the Consent to Treatment Policy (2015) and Mental Capacity Act (2005).

Forms can now be found on a designated Medicines Management Forms intranet page.

Training declaration forms related to Medicines Management internal training can be found on the Medicines Management Education & Training intranet page.